|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:DIP2B-SPATS2 (FusionGDB2 ID:22851) |
Fusion Gene Summary for DIP2B-SPATS2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: DIP2B-SPATS2 | Fusion gene ID: 22851 | Hgene | Tgene | Gene symbol | DIP2B | SPATS2 | Gene ID | 57609 | 65244 |
Gene name | disco interacting protein 2 homolog B | spermatogenesis associated serine rich 2 | |
Synonyms | - | Nbla00526|P59SCR|SCR59|SPATA10 | |
Cytomap | 12q13.12 | 12q13.12 | |
Type of gene | protein-coding | protein-coding | |
Description | disco-interacting protein 2 homolog BDIP2 disco-interacting protein 2 homolog B | spermatogenesis-associated serine-rich protein 2putative protein product of Nbla00526serine-rich spermatocytes and round spermatid 59 kDa proteinserine-rich spermatocytes and round spermatid protein | |
Modification date | 20200313 | 20200315 | |
UniProtAcc | Q9P265 | SPATS2L | |
Ensembl transtripts involved in fusion gene | ENST00000301180, | ENST00000547865, ENST00000552557, ENST00000321898, ENST00000553127, ENST00000552918, | |
Fusion gene scores | * DoF score | 19 X 15 X 11=3135 | 12 X 14 X 7=1176 |
# samples | 24 | 15 | |
** MAII score | log2(24/3135*10)=-3.70735913208088 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/1176*10)=-2.97085365434048 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: DIP2B [Title/Abstract] AND SPATS2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | DIP2B(51108379)-SPATS2(49919727), # samples:5 | ||
Anticipated loss of major functional domain due to fusion event. | DIP2B-SPATS2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. DIP2B-SPATS2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across DIP2B (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SPATS2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BLCA | TCGA-BL-A0C8-01A | DIP2B | chr12 | 51108379 | - | SPATS2 | chr12 | 49919727 | + |
ChimerDB4 | BLCA | TCGA-BL-A0C8-01A | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919727 | + |
ChimerDB4 | BLCA | TCGA-BL-A0C8-01A | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919861 | + |
ChimerDB4 | BLCA | TCGA-BL-A0C8-01B | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919727 | + |
ChimerDB4 | BLCA | TCGA-BL-A0C8 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + |
Top |
Fusion Gene ORF analysis for DIP2B-SPATS2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000301180 | ENST00000547865 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919727 | + |
5CDS-intron | ENST00000301180 | ENST00000547865 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919861 | + |
5CDS-intron | ENST00000301180 | ENST00000547865 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + |
5CDS-intron | ENST00000301180 | ENST00000552557 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919727 | + |
5CDS-intron | ENST00000301180 | ENST00000552557 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919861 | + |
5CDS-intron | ENST00000301180 | ENST00000552557 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + |
Frame-shift | ENST00000301180 | ENST00000321898 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919727 | + |
Frame-shift | ENST00000301180 | ENST00000321898 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919861 | + |
Frame-shift | ENST00000301180 | ENST00000321898 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + |
Frame-shift | ENST00000301180 | ENST00000553127 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919727 | + |
Frame-shift | ENST00000301180 | ENST00000553127 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919861 | + |
Frame-shift | ENST00000301180 | ENST00000553127 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + |
In-frame | ENST00000301180 | ENST00000552918 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919727 | + |
In-frame | ENST00000301180 | ENST00000552918 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919861 | + |
In-frame | ENST00000301180 | ENST00000552918 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000301180 | DIP2B | chr12 | 51108379 | + | ENST00000552918 | SPATS2 | chr12 | 49919727 | + | 4168 | 2885 | 34 | 2922 | 962 |
ENST00000301180 | DIP2B | chr12 | 51108379 | + | ENST00000552918 | SPATS2 | chr12 | 49919726 | + | 4168 | 2885 | 34 | 2922 | 962 |
ENST00000301180 | DIP2B | chr12 | 51108379 | + | ENST00000552918 | SPATS2 | chr12 | 49919861 | + | 4033 | 2885 | 34 | 2925 | 963 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000301180 | ENST00000552918 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919727 | + | 0.001104004 | 0.998896 |
ENST00000301180 | ENST00000552918 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + | 0.001104004 | 0.998896 |
ENST00000301180 | ENST00000552918 | DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919861 | + | 0.00108344 | 0.9989166 |
Top |
Fusion Genomic Features for DIP2B-SPATS2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + | 0.000301672 | 0.9996984 |
DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + | 0.000301672 | 0.9996984 |
DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + | 0.000301672 | 0.9996984 |
DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + | 0.000301672 | 0.9996984 |
DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + | 0.000301672 | 0.9996984 |
DIP2B | chr12 | 51108379 | + | SPATS2 | chr12 | 49919726 | + | 0.000301672 | 0.9996984 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for DIP2B-SPATS2 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:51108379/chr12:49919727) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
DIP2B | SPATS2 |
FUNCTION: Negatively regulates axonal outgrowth and is essential for normal synaptic transmission. Not required for regulation of axon polarity. Promotes acetylation of alpha-tubulin. {ECO:0000250|UniProtKB:Q3UH60}. | 558 |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | DIP2B | chr12:51108379 | chr12:49919726 | ENST00000301180 | + | 23 | 38 | 145_234 | 950 | 1577.0 | Compositional bias | Note=Ser-rich |
Hgene | DIP2B | chr12:51108379 | chr12:49919727 | ENST00000301180 | + | 23 | 38 | 145_234 | 950 | 1577.0 | Compositional bias | Note=Ser-rich |
Hgene | DIP2B | chr12:51108379 | chr12:49919861 | ENST00000301180 | + | 23 | 38 | 145_234 | 950 | 1577.0 | Compositional bias | Note=Ser-rich |
Hgene | DIP2B | chr12:51108379 | chr12:49919726 | ENST00000301180 | + | 23 | 38 | 12_131 | 950 | 1577.0 | Domain | DMAP1-binding |
Hgene | DIP2B | chr12:51108379 | chr12:49919727 | ENST00000301180 | + | 23 | 38 | 12_131 | 950 | 1577.0 | Domain | DMAP1-binding |
Hgene | DIP2B | chr12:51108379 | chr12:49919861 | ENST00000301180 | + | 23 | 38 | 12_131 | 950 | 1577.0 | Domain | DMAP1-binding |
Tgene | SPATS2 | chr12:51108379 | chr12:49919861 | ENST00000321898 | 0 | 13 | 364_414 | 0 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919861 | ENST00000321898 | 0 | 13 | 86_97 | 0 | 546.0 | Compositional bias | Note=Poly-Lys | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919861 | ENST00000552918 | 0 | 14 | 364_414 | 0 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919861 | ENST00000552918 | 0 | 14 | 86_97 | 0 | 546.0 | Compositional bias | Note=Poly-Lys | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919861 | ENST00000553127 | 0 | 15 | 364_414 | 0 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919861 | ENST00000553127 | 0 | 15 | 86_97 | 0 | 546.0 | Compositional bias | Note=Poly-Lys |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | DIP2B | chr12:51108379 | chr12:49919726 | ENST00000301180 | + | 23 | 38 | 1118_1121 | 950 | 1577.0 | Compositional bias | Note=Poly-Ala |
Hgene | DIP2B | chr12:51108379 | chr12:49919726 | ENST00000301180 | + | 23 | 38 | 1503_1506 | 950 | 1577.0 | Compositional bias | Note=Poly-Val |
Hgene | DIP2B | chr12:51108379 | chr12:49919726 | ENST00000301180 | + | 23 | 38 | 1534_1540 | 950 | 1577.0 | Compositional bias | Note=Poly-Val |
Hgene | DIP2B | chr12:51108379 | chr12:49919727 | ENST00000301180 | + | 23 | 38 | 1118_1121 | 950 | 1577.0 | Compositional bias | Note=Poly-Ala |
Hgene | DIP2B | chr12:51108379 | chr12:49919727 | ENST00000301180 | + | 23 | 38 | 1503_1506 | 950 | 1577.0 | Compositional bias | Note=Poly-Val |
Hgene | DIP2B | chr12:51108379 | chr12:49919727 | ENST00000301180 | + | 23 | 38 | 1534_1540 | 950 | 1577.0 | Compositional bias | Note=Poly-Val |
Hgene | DIP2B | chr12:51108379 | chr12:49919861 | ENST00000301180 | + | 23 | 38 | 1118_1121 | 950 | 1577.0 | Compositional bias | Note=Poly-Ala |
Hgene | DIP2B | chr12:51108379 | chr12:49919861 | ENST00000301180 | + | 23 | 38 | 1503_1506 | 950 | 1577.0 | Compositional bias | Note=Poly-Val |
Hgene | DIP2B | chr12:51108379 | chr12:49919861 | ENST00000301180 | + | 23 | 38 | 1534_1540 | 950 | 1577.0 | Compositional bias | Note=Poly-Val |
Tgene | SPATS2 | chr12:51108379 | chr12:49919726 | ENST00000321898 | 11 | 13 | 364_414 | 442 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919726 | ENST00000321898 | 11 | 13 | 86_97 | 442 | 546.0 | Compositional bias | Note=Poly-Lys | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919726 | ENST00000552918 | 12 | 14 | 364_414 | 442 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919726 | ENST00000552918 | 12 | 14 | 86_97 | 442 | 546.0 | Compositional bias | Note=Poly-Lys | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919726 | ENST00000553127 | 13 | 15 | 364_414 | 442 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919726 | ENST00000553127 | 13 | 15 | 86_97 | 442 | 546.0 | Compositional bias | Note=Poly-Lys | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919727 | ENST00000321898 | 11 | 13 | 364_414 | 442 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919727 | ENST00000321898 | 11 | 13 | 86_97 | 442 | 546.0 | Compositional bias | Note=Poly-Lys | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919727 | ENST00000552918 | 12 | 14 | 364_414 | 442 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919727 | ENST00000552918 | 12 | 14 | 86_97 | 442 | 546.0 | Compositional bias | Note=Poly-Lys | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919727 | ENST00000553127 | 13 | 15 | 364_414 | 442 | 546.0 | Compositional bias | Note=Ser-rich | |
Tgene | SPATS2 | chr12:51108379 | chr12:49919727 | ENST00000553127 | 13 | 15 | 86_97 | 442 | 546.0 | Compositional bias | Note=Poly-Lys |
Top |
Fusion Gene Sequence for DIP2B-SPATS2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>22851_22851_1_DIP2B-SPATS2_DIP2B_chr12_51108379_ENST00000301180_SPATS2_chr12_49919726_ENST00000552918_length(transcript)=4168nt_BP=2885nt TCTTGTCTTCCGGAGTGTGGCTGGCGGAGCTGGGATGGCGGAACGAGGCCTGGAGCCGTCGCCGGCCGCGGTGGCGGCGCTGCCGCCTGA AGTGCGGGCGCAGCTGGCGGAGCTGGAGCTGGAGCTCTCGGAGGGGGACATCACCCAGAAGGGCTATGAAAAGAAAAGGTCCAAACTCCT ATCTCCTTACAGCCCGCAGACACAAGAAACTGATTCAGCAGTACAGAAAGAACTTAGAAACCAGACACCTGCTCCATCTGCAGCTCAAAC TTCTGCTCCCTCTAAGTACCACCGAACTCGATCTGGGGGAGCCAGGGATGAACGATATCGATCAGATATCCACACAGAAGCAGTTCAGGC TGCACTGGCAAAGCATAAAGAACAGAAGATGGCTTTGCCCATGCCAACCAAAAGGCGATCCACATTTGTTCAGTCTCCTGCAGATGCCTG CACACCTCCTGACACATCTTCGGCCTCTGAGGATGAGGGCTCTCTGAGACGCCAAGCTGCGCTCTCTGCTGCCTTGCAACAGAGCTTACA GAATGCTGAGTCCTGGATCAACCGTTCAATTCAGGGATCGTCCACTTCTTCATCCGCATCTTCTACGCTGTCCCACGGAGAGGTCAAAGG AACCAGTGGGTCTCTAGCTGATGTATTTGCCAATACTCGAATAGAGAATTTCTCTGCTCCTCCTGATGTCACTACAACTACCTCTTCCTC CTCATCATCTTCCTCAATTCGCCCAGCAAACATTGACCTGCCCCCCTCGGGGATAGTTAAAGGCATGCACAAAGGATCCAACAGGTCCAG CCTTATGGATACAGCTGATGGTGTTCCTGTCAGTAGCAGAGTATCTACAAAAATCCAGCAGCTTCTGAACACTCTGAAACGACCCAAAAG GCCTCCCTTAAAGGAATTTTTTGTGGATGACTCTGAAGAAATTGTGGAAGTACCTCAGCCAGACCCCAACCAGCCCAAGCCGGAGGGACG GCAGATGACCCCTGTGAAAGGAGAGCCTTTAGGAGTCATCTGTAACTGGCCTCCTGCTCTTGAATCTGCCCTGCAGCGCTGGGGTACCAC TCAAGCAAAATGCTCCTGTCTGACTGCACTGGACATGACAGGGAAACCAGTTTACACTCTTACATATGGAAAGTTGTGGAGCAGAAGTTT AAAGTTGGCCTACACACTTCTTAATAAACTGGGGACCAAAAATGAACCTGTGTTAAAACCTGGAGACAGGGTAGCCCTGGTTTACCCCAA CAATGATCCAGTCATGTTTATGGTGGCTTTCTATGGATGCCTCCTGGCAGAAGTGATTCCAGTGCCTATAGAGGTACCTCTTACCAGAAA GGATGCTGGAGGTCAGCAGATTGGCTTCTTGCTAGGAAGCTGTGGTATTGCCTTAGCTCTTACCAGTGAAGTTTGTCTAAAAGGACTGCC AAAAACCCAGAATGGAGAAATTGTACAGTTTAAAGGTTGGCCCCGGCTCAAATGGGTTGTAACAGATTCCAAGTACCTTTCAAAGCCACC GAAAGACTGGCAGCCACACATCTCACCTGCTGGGACAGAACCGGCATACATTGAGTATAAAACAAGCAAAGAAGGGAGTGTAATGGGAGT TACAGTATCCCGGCTTGCAATGTTGTCTCACTGCCAAGCTCTGTCGCAGGCCTGCAATTATTCTGAAGGGGAAACAATAGTAAATGTCTT AGACTTTAAGAAGGATGCTGGGCTGTGGCACGGCATGTTTGCGAATGTAATGAATAAGATGCACACAATCAGCGTACCCTACTCTGTTAT GAAAACCTGTCCTCTCTCTTGGGTCCAAAGAGTACATGCTCACAAAGCCAAGGTAGCTTTAGTAAAATGTCGGGACTTGCACTGGGCTAT GATGGCACATCGGGACCAAAGAGACGTGAGCTTGAGTTCCCTCCGAATGTTAATTGTGACTGATGGAGCTAACCCCTGGTCCGTGTCATC CTGTGATGCCTTCCTGAGTCTGTTCCAAAGTCATGGACTGAAGCCTGAGGCCATCTGTCCGTGCGCCACGTCTGCTGAAGCCATGACTGT AGCAATCCGCAGGCCTGGAGTTCCAGGAGCCCCTTTGCCAGGAAGAGCCATTCTCTCAATGAATGGATTGAGCTATGGGGTAATACGGGT CAATACTGAAGATAAAAATTCAGCACTGACGGTCCAGGATGTAGGGCATGTAATGCCTGGTGGGATGATGTGCATTGTGAAACCAGATGG ACCTCCCCAGCTCTGCAAAACAGATGAAATTGGAGAAATCTGTGTTAGCTCCAGAACTGGAGGCATGATGTACTTTGGGCTTGCTGGTGT GACAAAAAATACATTTGAGGTAATTCCAGTGAATTCTGCAGGCTCTCCTGTTGGGGATGTGCCATTCATCCGATCAGGATTGCTGGGGTT TGTAGGGCCGGGTAGTTTGGTGTTCGTGGTTGGGAAAATGGATGGCTTACTGATGGTTAGTGGTCGAAGACATAATGCTGATGACATTGT TGCTACTGGATTGGCTGTAGAATCAATAAAGACTGTTTATAGAGGAAGAATTGCTGTGTTTTCTGTGTCTGTATTTTATGATGAGCGCAT TGTGGTGGTTGCGGAACAAAGACCTGATGCTTCTGAGGAAGATAGTTTCCAGTGGATGAGCCGCGTGCTGCAGGCGATCGATAGCATTCA TCAAGTGGGGGTTTATTGTCTTGCTCTGGTGCCAGCCAATACATTGCCAAAAACTCCACTAGGAGGAATCCATATATCTCAGACGAAACA ACTCTTTCTGGAGGGATCACTGCATCCTTGCAACATCCTCATGTGCCCCCATACATGTGTGACAAACTTGCCAAAGCCCCGGCAAAAACA ACCAGGTATTGCCAGGGAACAGACGAGGAGGACAGGGCTATAGGCCACAAGGCCAAAAGTCCAATGACCCCATGAACCAAGGGCGGCATG ACAGTATGGGTCGTTACAGAAACAGCTCGTGGTATTCATCTGGTTCCAGGTATCAGAGTGCTCCATCTCAGGCACCAGGAAACACCATTG AAAGAGGCCAGACTCACTCTGCAGGGACCAATGGAACTGGAGTCAGCATGGAGCCCAGCCCTCCCACGCCTTCATTCAAAAAGGGGCTCC CCCAGCGCAAACCCAGGACCTCTCAGACTGAAGCCGTGAACTCTTGAGAGAAAATCCAGTTGGCCTCTCTCCTCTATCCACACAATTCAA CTTGATAACTGGACTTTAGGAAACTTACAGTTAGATGTAATAACAAAAAGAAGTTTATGCGTATCACTTTTTGTGCCATTCTAAGTATTT TTGGTTTCTTGTCTCCTTATTTCCTCTTTACCATTTTTGGAGGGGAAGCTATTTTTTTTCCTTGATCTTTCCCAGTGATATGGATTGAAT CTGGTTGGTCATTTCCACCAGGAATCAGAGGCAGCTGTTACCAGGTTTCGGCCTTCCAGTTGATCCCTCCACTGTCCAGGCTGTCTCAGG AGGAGGTGAATCAGAGCTAGTCTGTCACCTTTCCAATCTAAGCCGAAGCCACAGGTGCCTGACAGGTTCCCTTCTAACAACTATTTGACC AAGAGAGGCAATCAGGGGGTTGTATACTGCACTGGATTCGCCAGAGAAGGGAAAATTTAATTAGTGAAAAGGAAAGAACACTAGGAAACA TTTGAGAACCTGCCTCTATCCCAGAATGTGCTGGAGATTTGACACTCAAATCAGTGTTTAGTCTTCTGCTTGGCACCATAGCTTAACCTG CAGTTTCTTCAAAATGCCCAATGCCTTGTTTCCTATTACCTTAGATTGCAAACCAGTCTAGGGAAGTCTATGAGAAAGTAGCATTTAATT AAAGTTTAAAAAAAAAAAGGTTGGGCGTTGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGTGGATCACTAGGTCAG GAGTTCAAGACCAGCCTGGCCAACATGGTGAAACCCTGTCTGTACTAAAAATACAAAAATTAGCTGAGCATGGTGGCGTGTGCCTGTAAT CTCAGCTACTCAGGAGGCTGAGGCAGGAGAATCGCTTGAACCCAGGAGGCGGAGGCTGCAGTGAGCTGAGATTGTGCCACTGCACTCCAG >22851_22851_1_DIP2B-SPATS2_DIP2B_chr12_51108379_ENST00000301180_SPATS2_chr12_49919726_ENST00000552918_length(amino acids)=962AA_BP= MAERGLEPSPAAVAALPPEVRAQLAELELELSEGDITQKGYEKKRSKLLSPYSPQTQETDSAVQKELRNQTPAPSAAQTSAPSKYHRTRS GGARDERYRSDIHTEAVQAALAKHKEQKMALPMPTKRRSTFVQSPADACTPPDTSSASEDEGSLRRQAALSAALQQSLQNAESWINRSIQ GSSTSSSASSTLSHGEVKGTSGSLADVFANTRIENFSAPPDVTTTTSSSSSSSSIRPANIDLPPSGIVKGMHKGSNRSSLMDTADGVPVS SRVSTKIQQLLNTLKRPKRPPLKEFFVDDSEEIVEVPQPDPNQPKPEGRQMTPVKGEPLGVICNWPPALESALQRWGTTQAKCSCLTALD MTGKPVYTLTYGKLWSRSLKLAYTLLNKLGTKNEPVLKPGDRVALVYPNNDPVMFMVAFYGCLLAEVIPVPIEVPLTRKDAGGQQIGFLL GSCGIALALTSEVCLKGLPKTQNGEIVQFKGWPRLKWVVTDSKYLSKPPKDWQPHISPAGTEPAYIEYKTSKEGSVMGVTVSRLAMLSHC QALSQACNYSEGETIVNVLDFKKDAGLWHGMFANVMNKMHTISVPYSVMKTCPLSWVQRVHAHKAKVALVKCRDLHWAMMAHRDQRDVSL SSLRMLIVTDGANPWSVSSCDAFLSLFQSHGLKPEAICPCATSAEAMTVAIRRPGVPGAPLPGRAILSMNGLSYGVIRVNTEDKNSALTV QDVGHVMPGGMMCIVKPDGPPQLCKTDEIGEICVSSRTGGMMYFGLAGVTKNTFEVIPVNSAGSPVGDVPFIRSGLLGFVGPGSLVFVVG KMDGLLMVSGRRHNADDIVATGLAVESIKTVYRGRIAVFSVSVFYDERIVVVAEQRPDASEEDSFQWMSRVLQAIDSIHQVGVYCLALVP -------------------------------------------------------------- >22851_22851_2_DIP2B-SPATS2_DIP2B_chr12_51108379_ENST00000301180_SPATS2_chr12_49919727_ENST00000552918_length(transcript)=4168nt_BP=2885nt TCTTGTCTTCCGGAGTGTGGCTGGCGGAGCTGGGATGGCGGAACGAGGCCTGGAGCCGTCGCCGGCCGCGGTGGCGGCGCTGCCGCCTGA AGTGCGGGCGCAGCTGGCGGAGCTGGAGCTGGAGCTCTCGGAGGGGGACATCACCCAGAAGGGCTATGAAAAGAAAAGGTCCAAACTCCT ATCTCCTTACAGCCCGCAGACACAAGAAACTGATTCAGCAGTACAGAAAGAACTTAGAAACCAGACACCTGCTCCATCTGCAGCTCAAAC TTCTGCTCCCTCTAAGTACCACCGAACTCGATCTGGGGGAGCCAGGGATGAACGATATCGATCAGATATCCACACAGAAGCAGTTCAGGC TGCACTGGCAAAGCATAAAGAACAGAAGATGGCTTTGCCCATGCCAACCAAAAGGCGATCCACATTTGTTCAGTCTCCTGCAGATGCCTG CACACCTCCTGACACATCTTCGGCCTCTGAGGATGAGGGCTCTCTGAGACGCCAAGCTGCGCTCTCTGCTGCCTTGCAACAGAGCTTACA GAATGCTGAGTCCTGGATCAACCGTTCAATTCAGGGATCGTCCACTTCTTCATCCGCATCTTCTACGCTGTCCCACGGAGAGGTCAAAGG AACCAGTGGGTCTCTAGCTGATGTATTTGCCAATACTCGAATAGAGAATTTCTCTGCTCCTCCTGATGTCACTACAACTACCTCTTCCTC CTCATCATCTTCCTCAATTCGCCCAGCAAACATTGACCTGCCCCCCTCGGGGATAGTTAAAGGCATGCACAAAGGATCCAACAGGTCCAG CCTTATGGATACAGCTGATGGTGTTCCTGTCAGTAGCAGAGTATCTACAAAAATCCAGCAGCTTCTGAACACTCTGAAACGACCCAAAAG GCCTCCCTTAAAGGAATTTTTTGTGGATGACTCTGAAGAAATTGTGGAAGTACCTCAGCCAGACCCCAACCAGCCCAAGCCGGAGGGACG GCAGATGACCCCTGTGAAAGGAGAGCCTTTAGGAGTCATCTGTAACTGGCCTCCTGCTCTTGAATCTGCCCTGCAGCGCTGGGGTACCAC TCAAGCAAAATGCTCCTGTCTGACTGCACTGGACATGACAGGGAAACCAGTTTACACTCTTACATATGGAAAGTTGTGGAGCAGAAGTTT AAAGTTGGCCTACACACTTCTTAATAAACTGGGGACCAAAAATGAACCTGTGTTAAAACCTGGAGACAGGGTAGCCCTGGTTTACCCCAA CAATGATCCAGTCATGTTTATGGTGGCTTTCTATGGATGCCTCCTGGCAGAAGTGATTCCAGTGCCTATAGAGGTACCTCTTACCAGAAA GGATGCTGGAGGTCAGCAGATTGGCTTCTTGCTAGGAAGCTGTGGTATTGCCTTAGCTCTTACCAGTGAAGTTTGTCTAAAAGGACTGCC AAAAACCCAGAATGGAGAAATTGTACAGTTTAAAGGTTGGCCCCGGCTCAAATGGGTTGTAACAGATTCCAAGTACCTTTCAAAGCCACC GAAAGACTGGCAGCCACACATCTCACCTGCTGGGACAGAACCGGCATACATTGAGTATAAAACAAGCAAAGAAGGGAGTGTAATGGGAGT TACAGTATCCCGGCTTGCAATGTTGTCTCACTGCCAAGCTCTGTCGCAGGCCTGCAATTATTCTGAAGGGGAAACAATAGTAAATGTCTT AGACTTTAAGAAGGATGCTGGGCTGTGGCACGGCATGTTTGCGAATGTAATGAATAAGATGCACACAATCAGCGTACCCTACTCTGTTAT GAAAACCTGTCCTCTCTCTTGGGTCCAAAGAGTACATGCTCACAAAGCCAAGGTAGCTTTAGTAAAATGTCGGGACTTGCACTGGGCTAT GATGGCACATCGGGACCAAAGAGACGTGAGCTTGAGTTCCCTCCGAATGTTAATTGTGACTGATGGAGCTAACCCCTGGTCCGTGTCATC CTGTGATGCCTTCCTGAGTCTGTTCCAAAGTCATGGACTGAAGCCTGAGGCCATCTGTCCGTGCGCCACGTCTGCTGAAGCCATGACTGT AGCAATCCGCAGGCCTGGAGTTCCAGGAGCCCCTTTGCCAGGAAGAGCCATTCTCTCAATGAATGGATTGAGCTATGGGGTAATACGGGT CAATACTGAAGATAAAAATTCAGCACTGACGGTCCAGGATGTAGGGCATGTAATGCCTGGTGGGATGATGTGCATTGTGAAACCAGATGG ACCTCCCCAGCTCTGCAAAACAGATGAAATTGGAGAAATCTGTGTTAGCTCCAGAACTGGAGGCATGATGTACTTTGGGCTTGCTGGTGT GACAAAAAATACATTTGAGGTAATTCCAGTGAATTCTGCAGGCTCTCCTGTTGGGGATGTGCCATTCATCCGATCAGGATTGCTGGGGTT TGTAGGGCCGGGTAGTTTGGTGTTCGTGGTTGGGAAAATGGATGGCTTACTGATGGTTAGTGGTCGAAGACATAATGCTGATGACATTGT TGCTACTGGATTGGCTGTAGAATCAATAAAGACTGTTTATAGAGGAAGAATTGCTGTGTTTTCTGTGTCTGTATTTTATGATGAGCGCAT TGTGGTGGTTGCGGAACAAAGACCTGATGCTTCTGAGGAAGATAGTTTCCAGTGGATGAGCCGCGTGCTGCAGGCGATCGATAGCATTCA TCAAGTGGGGGTTTATTGTCTTGCTCTGGTGCCAGCCAATACATTGCCAAAAACTCCACTAGGAGGAATCCATATATCTCAGACGAAACA ACTCTTTCTGGAGGGATCACTGCATCCTTGCAACATCCTCATGTGCCCCCATACATGTGTGACAAACTTGCCAAAGCCCCGGCAAAAACA ACCAGGTATTGCCAGGGAACAGACGAGGAGGACAGGGCTATAGGCCACAAGGCCAAAAGTCCAATGACCCCATGAACCAAGGGCGGCATG ACAGTATGGGTCGTTACAGAAACAGCTCGTGGTATTCATCTGGTTCCAGGTATCAGAGTGCTCCATCTCAGGCACCAGGAAACACCATTG AAAGAGGCCAGACTCACTCTGCAGGGACCAATGGAACTGGAGTCAGCATGGAGCCCAGCCCTCCCACGCCTTCATTCAAAAAGGGGCTCC CCCAGCGCAAACCCAGGACCTCTCAGACTGAAGCCGTGAACTCTTGAGAGAAAATCCAGTTGGCCTCTCTCCTCTATCCACACAATTCAA CTTGATAACTGGACTTTAGGAAACTTACAGTTAGATGTAATAACAAAAAGAAGTTTATGCGTATCACTTTTTGTGCCATTCTAAGTATTT TTGGTTTCTTGTCTCCTTATTTCCTCTTTACCATTTTTGGAGGGGAAGCTATTTTTTTTCCTTGATCTTTCCCAGTGATATGGATTGAAT CTGGTTGGTCATTTCCACCAGGAATCAGAGGCAGCTGTTACCAGGTTTCGGCCTTCCAGTTGATCCCTCCACTGTCCAGGCTGTCTCAGG AGGAGGTGAATCAGAGCTAGTCTGTCACCTTTCCAATCTAAGCCGAAGCCACAGGTGCCTGACAGGTTCCCTTCTAACAACTATTTGACC AAGAGAGGCAATCAGGGGGTTGTATACTGCACTGGATTCGCCAGAGAAGGGAAAATTTAATTAGTGAAAAGGAAAGAACACTAGGAAACA TTTGAGAACCTGCCTCTATCCCAGAATGTGCTGGAGATTTGACACTCAAATCAGTGTTTAGTCTTCTGCTTGGCACCATAGCTTAACCTG CAGTTTCTTCAAAATGCCCAATGCCTTGTTTCCTATTACCTTAGATTGCAAACCAGTCTAGGGAAGTCTATGAGAAAGTAGCATTTAATT AAAGTTTAAAAAAAAAAAGGTTGGGCGTTGTGGCTCATGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGTGGATCACTAGGTCAG GAGTTCAAGACCAGCCTGGCCAACATGGTGAAACCCTGTCTGTACTAAAAATACAAAAATTAGCTGAGCATGGTGGCGTGTGCCTGTAAT CTCAGCTACTCAGGAGGCTGAGGCAGGAGAATCGCTTGAACCCAGGAGGCGGAGGCTGCAGTGAGCTGAGATTGTGCCACTGCACTCCAG >22851_22851_2_DIP2B-SPATS2_DIP2B_chr12_51108379_ENST00000301180_SPATS2_chr12_49919727_ENST00000552918_length(amino acids)=962AA_BP= MAERGLEPSPAAVAALPPEVRAQLAELELELSEGDITQKGYEKKRSKLLSPYSPQTQETDSAVQKELRNQTPAPSAAQTSAPSKYHRTRS GGARDERYRSDIHTEAVQAALAKHKEQKMALPMPTKRRSTFVQSPADACTPPDTSSASEDEGSLRRQAALSAALQQSLQNAESWINRSIQ GSSTSSSASSTLSHGEVKGTSGSLADVFANTRIENFSAPPDVTTTTSSSSSSSSIRPANIDLPPSGIVKGMHKGSNRSSLMDTADGVPVS SRVSTKIQQLLNTLKRPKRPPLKEFFVDDSEEIVEVPQPDPNQPKPEGRQMTPVKGEPLGVICNWPPALESALQRWGTTQAKCSCLTALD MTGKPVYTLTYGKLWSRSLKLAYTLLNKLGTKNEPVLKPGDRVALVYPNNDPVMFMVAFYGCLLAEVIPVPIEVPLTRKDAGGQQIGFLL GSCGIALALTSEVCLKGLPKTQNGEIVQFKGWPRLKWVVTDSKYLSKPPKDWQPHISPAGTEPAYIEYKTSKEGSVMGVTVSRLAMLSHC QALSQACNYSEGETIVNVLDFKKDAGLWHGMFANVMNKMHTISVPYSVMKTCPLSWVQRVHAHKAKVALVKCRDLHWAMMAHRDQRDVSL SSLRMLIVTDGANPWSVSSCDAFLSLFQSHGLKPEAICPCATSAEAMTVAIRRPGVPGAPLPGRAILSMNGLSYGVIRVNTEDKNSALTV QDVGHVMPGGMMCIVKPDGPPQLCKTDEIGEICVSSRTGGMMYFGLAGVTKNTFEVIPVNSAGSPVGDVPFIRSGLLGFVGPGSLVFVVG KMDGLLMVSGRRHNADDIVATGLAVESIKTVYRGRIAVFSVSVFYDERIVVVAEQRPDASEEDSFQWMSRVLQAIDSIHQVGVYCLALVP -------------------------------------------------------------- >22851_22851_3_DIP2B-SPATS2_DIP2B_chr12_51108379_ENST00000301180_SPATS2_chr12_49919861_ENST00000552918_length(transcript)=4033nt_BP=2885nt TCTTGTCTTCCGGAGTGTGGCTGGCGGAGCTGGGATGGCGGAACGAGGCCTGGAGCCGTCGCCGGCCGCGGTGGCGGCGCTGCCGCCTGA AGTGCGGGCGCAGCTGGCGGAGCTGGAGCTGGAGCTCTCGGAGGGGGACATCACCCAGAAGGGCTATGAAAAGAAAAGGTCCAAACTCCT ATCTCCTTACAGCCCGCAGACACAAGAAACTGATTCAGCAGTACAGAAAGAACTTAGAAACCAGACACCTGCTCCATCTGCAGCTCAAAC TTCTGCTCCCTCTAAGTACCACCGAACTCGATCTGGGGGAGCCAGGGATGAACGATATCGATCAGATATCCACACAGAAGCAGTTCAGGC TGCACTGGCAAAGCATAAAGAACAGAAGATGGCTTTGCCCATGCCAACCAAAAGGCGATCCACATTTGTTCAGTCTCCTGCAGATGCCTG CACACCTCCTGACACATCTTCGGCCTCTGAGGATGAGGGCTCTCTGAGACGCCAAGCTGCGCTCTCTGCTGCCTTGCAACAGAGCTTACA GAATGCTGAGTCCTGGATCAACCGTTCAATTCAGGGATCGTCCACTTCTTCATCCGCATCTTCTACGCTGTCCCACGGAGAGGTCAAAGG AACCAGTGGGTCTCTAGCTGATGTATTTGCCAATACTCGAATAGAGAATTTCTCTGCTCCTCCTGATGTCACTACAACTACCTCTTCCTC CTCATCATCTTCCTCAATTCGCCCAGCAAACATTGACCTGCCCCCCTCGGGGATAGTTAAAGGCATGCACAAAGGATCCAACAGGTCCAG CCTTATGGATACAGCTGATGGTGTTCCTGTCAGTAGCAGAGTATCTACAAAAATCCAGCAGCTTCTGAACACTCTGAAACGACCCAAAAG GCCTCCCTTAAAGGAATTTTTTGTGGATGACTCTGAAGAAATTGTGGAAGTACCTCAGCCAGACCCCAACCAGCCCAAGCCGGAGGGACG GCAGATGACCCCTGTGAAAGGAGAGCCTTTAGGAGTCATCTGTAACTGGCCTCCTGCTCTTGAATCTGCCCTGCAGCGCTGGGGTACCAC TCAAGCAAAATGCTCCTGTCTGACTGCACTGGACATGACAGGGAAACCAGTTTACACTCTTACATATGGAAAGTTGTGGAGCAGAAGTTT AAAGTTGGCCTACACACTTCTTAATAAACTGGGGACCAAAAATGAACCTGTGTTAAAACCTGGAGACAGGGTAGCCCTGGTTTACCCCAA CAATGATCCAGTCATGTTTATGGTGGCTTTCTATGGATGCCTCCTGGCAGAAGTGATTCCAGTGCCTATAGAGGTACCTCTTACCAGAAA GGATGCTGGAGGTCAGCAGATTGGCTTCTTGCTAGGAAGCTGTGGTATTGCCTTAGCTCTTACCAGTGAAGTTTGTCTAAAAGGACTGCC AAAAACCCAGAATGGAGAAATTGTACAGTTTAAAGGTTGGCCCCGGCTCAAATGGGTTGTAACAGATTCCAAGTACCTTTCAAAGCCACC GAAAGACTGGCAGCCACACATCTCACCTGCTGGGACAGAACCGGCATACATTGAGTATAAAACAAGCAAAGAAGGGAGTGTAATGGGAGT TACAGTATCCCGGCTTGCAATGTTGTCTCACTGCCAAGCTCTGTCGCAGGCCTGCAATTATTCTGAAGGGGAAACAATAGTAAATGTCTT AGACTTTAAGAAGGATGCTGGGCTGTGGCACGGCATGTTTGCGAATGTAATGAATAAGATGCACACAATCAGCGTACCCTACTCTGTTAT GAAAACCTGTCCTCTCTCTTGGGTCCAAAGAGTACATGCTCACAAAGCCAAGGTAGCTTTAGTAAAATGTCGGGACTTGCACTGGGCTAT GATGGCACATCGGGACCAAAGAGACGTGAGCTTGAGTTCCCTCCGAATGTTAATTGTGACTGATGGAGCTAACCCCTGGTCCGTGTCATC CTGTGATGCCTTCCTGAGTCTGTTCCAAAGTCATGGACTGAAGCCTGAGGCCATCTGTCCGTGCGCCACGTCTGCTGAAGCCATGACTGT AGCAATCCGCAGGCCTGGAGTTCCAGGAGCCCCTTTGCCAGGAAGAGCCATTCTCTCAATGAATGGATTGAGCTATGGGGTAATACGGGT CAATACTGAAGATAAAAATTCAGCACTGACGGTCCAGGATGTAGGGCATGTAATGCCTGGTGGGATGATGTGCATTGTGAAACCAGATGG ACCTCCCCAGCTCTGCAAAACAGATGAAATTGGAGAAATCTGTGTTAGCTCCAGAACTGGAGGCATGATGTACTTTGGGCTTGCTGGTGT GACAAAAAATACATTTGAGGTAATTCCAGTGAATTCTGCAGGCTCTCCTGTTGGGGATGTGCCATTCATCCGATCAGGATTGCTGGGGTT TGTAGGGCCGGGTAGTTTGGTGTTCGTGGTTGGGAAAATGGATGGCTTACTGATGGTTAGTGGTCGAAGACATAATGCTGATGACATTGT TGCTACTGGATTGGCTGTAGAATCAATAAAGACTGTTTATAGAGGAAGAATTGCTGTGTTTTCTGTGTCTGTATTTTATGATGAGCGCAT TGTGGTGGTTGCGGAACAAAGACCTGATGCTTCTGAGGAAGATAGTTTCCAGTGGATGAGCCGCGTGCTGCAGGCGATCGATAGCATTCA TCAAGTGGGGGTTTATTGTCTTGCTCTGGTGCCAGCCAATACATTGCCAAAAACTCCACTAGGAGGAATCCATATATCTCAGACGAAACA ACTCTTTCTGGAGGGATCACTGCATCCTTGCAACATCCTCATGTGCCCCCATACATGTGTGACAAACTTGCCAAAGCCCCGGCAAAAACA ACCAGTATCAGAGTGCTCCATCTCAGGCACCAGGAAACACCATTGAAAGAGGCCAGACTCACTCTGCAGGGACCAATGGAACTGGAGTCA GCATGGAGCCCAGCCCTCCCACGCCTTCATTCAAAAAGGGGCTCCCCCAGCGCAAACCCAGGACCTCTCAGACTGAAGCCGTGAACTCTT GAGAGAAAATCCAGTTGGCCTCTCTCCTCTATCCACACAATTCAACTTGATAACTGGACTTTAGGAAACTTACAGTTAGATGTAATAACA AAAAGAAGTTTATGCGTATCACTTTTTGTGCCATTCTAAGTATTTTTGGTTTCTTGTCTCCTTATTTCCTCTTTACCATTTTTGGAGGGG AAGCTATTTTTTTTCCTTGATCTTTCCCAGTGATATGGATTGAATCTGGTTGGTCATTTCCACCAGGAATCAGAGGCAGCTGTTACCAGG TTTCGGCCTTCCAGTTGATCCCTCCACTGTCCAGGCTGTCTCAGGAGGAGGTGAATCAGAGCTAGTCTGTCACCTTTCCAATCTAAGCCG AAGCCACAGGTGCCTGACAGGTTCCCTTCTAACAACTATTTGACCAAGAGAGGCAATCAGGGGGTTGTATACTGCACTGGATTCGCCAGA GAAGGGAAAATTTAATTAGTGAAAAGGAAAGAACACTAGGAAACATTTGAGAACCTGCCTCTATCCCAGAATGTGCTGGAGATTTGACAC TCAAATCAGTGTTTAGTCTTCTGCTTGGCACCATAGCTTAACCTGCAGTTTCTTCAAAATGCCCAATGCCTTGTTTCCTATTACCTTAGA TTGCAAACCAGTCTAGGGAAGTCTATGAGAAAGTAGCATTTAATTAAAGTTTAAAAAAAAAAAGGTTGGGCGTTGTGGCTCATGCCTGTA ATCCCAGCACTTTGGGAGGCTGAGGCGGGTGGATCACTAGGTCAGGAGTTCAAGACCAGCCTGGCCAACATGGTGAAACCCTGTCTGTAC TAAAAATACAAAAATTAGCTGAGCATGGTGGCGTGTGCCTGTAATCTCAGCTACTCAGGAGGCTGAGGCAGGAGAATCGCTTGAACCCAG >22851_22851_3_DIP2B-SPATS2_DIP2B_chr12_51108379_ENST00000301180_SPATS2_chr12_49919861_ENST00000552918_length(amino acids)=963AA_BP= MAERGLEPSPAAVAALPPEVRAQLAELELELSEGDITQKGYEKKRSKLLSPYSPQTQETDSAVQKELRNQTPAPSAAQTSAPSKYHRTRS GGARDERYRSDIHTEAVQAALAKHKEQKMALPMPTKRRSTFVQSPADACTPPDTSSASEDEGSLRRQAALSAALQQSLQNAESWINRSIQ GSSTSSSASSTLSHGEVKGTSGSLADVFANTRIENFSAPPDVTTTTSSSSSSSSIRPANIDLPPSGIVKGMHKGSNRSSLMDTADGVPVS SRVSTKIQQLLNTLKRPKRPPLKEFFVDDSEEIVEVPQPDPNQPKPEGRQMTPVKGEPLGVICNWPPALESALQRWGTTQAKCSCLTALD MTGKPVYTLTYGKLWSRSLKLAYTLLNKLGTKNEPVLKPGDRVALVYPNNDPVMFMVAFYGCLLAEVIPVPIEVPLTRKDAGGQQIGFLL GSCGIALALTSEVCLKGLPKTQNGEIVQFKGWPRLKWVVTDSKYLSKPPKDWQPHISPAGTEPAYIEYKTSKEGSVMGVTVSRLAMLSHC QALSQACNYSEGETIVNVLDFKKDAGLWHGMFANVMNKMHTISVPYSVMKTCPLSWVQRVHAHKAKVALVKCRDLHWAMMAHRDQRDVSL SSLRMLIVTDGANPWSVSSCDAFLSLFQSHGLKPEAICPCATSAEAMTVAIRRPGVPGAPLPGRAILSMNGLSYGVIRVNTEDKNSALTV QDVGHVMPGGMMCIVKPDGPPQLCKTDEIGEICVSSRTGGMMYFGLAGVTKNTFEVIPVNSAGSPVGDVPFIRSGLLGFVGPGSLVFVVG KMDGLLMVSGRRHNADDIVATGLAVESIKTVYRGRIAVFSVSVFYDERIVVVAEQRPDASEEDSFQWMSRVLQAIDSIHQVGVYCLALVP -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for DIP2B-SPATS2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DIP2B-SPATS2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for DIP2B-SPATS2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |